The COVID-19 pandemic and its effects on follow-up of patients with early breast cancer: A patient survey

Purpose Despite limited evidence supporting its effectiveness, most guidelines recommend long-term, routinely scheduled in-person surveillance of patients with early breast cancer (EBC). The COVID-19 pandemic led to increased use of virtual care. This survey evaluated patient perspectives on follow-up care. Methods Patients with EBC undergoing surveillance were surveyed about follow-up protocols, perceptions, and interest in clinical trials assessing different follow-up strategies. Results Of 402 approached patients 270 completed the survey (response rate 67%). Median age 62.5 years (range 25–86) and median time since breast cancer diagnosis was 3.8 years (range